Valuation: Terumo Corporation

Market Cap 3,563B 22.35B 19.41B 18.02B 16.62B 31.31B 2,133B 31.88B 213B 83.55B 1,060B 83.91B 82.08B P/E 2027 *
21.2x
P/E 2028 * 19x
Enterprise Value 3,639B 22.82B 19.82B 18.41B 16.98B 31.98B 2,179B 32.56B 218B 85.33B 1,082B 85.7B 83.83B EV / Sales 2027 *
2.93x
EV / Sales 2028 * 2.71x
Free-Float
97.07%
Yield 2027 *
1.49%
Yield 2028 * 1.66%
1 day+1.39%
1 week+9.85%
Current month+8.12%
1 month+7.50%
3 months+17.51%
6 months+20.90%
Current year+6.41%
1 week 2,133
Extreme 2133
2,459
1 month 2,133
Extreme 2133
2,459
Current year 1,900
Extreme 1900
2,463
1 year 1,900
Extreme 1900
2,818
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+1.39%+9.85%-6.45%+6.46% 21.45B
-2.65%+4.55%-18.06%-5.39% 187B
-1.16%+4.19%-6.75%-2.63% 112B
-2.51%+2.37%+7.02%+67.09% 61.99B
+0.32%-4.81%+25.21%+49.80% 48.52B
-6.38%+8.06%-8.95%-40.67% 46.4B
+0.05%+3.96% - - 33.89B
+1.58%+5.55%-16.47%-40.28% 28.99B
+3.24%-4.70%+35.95%-7.95% 23.75B
-1.32%+9.33%+0.45%+2.11% 22.89B
Average -1.01%+4.76%+1.33%+3.17% 58.68B
Weighted average by Cap. -1.55%+5.64%-4.78%+4.01%

Financials

2027 *2028 *
Net sales 1,241B 7.79B 6.76B 6.28B 5.79B 10.91B 743B 11.11B 74.34B 29.11B 369B 29.24B 28.6B 1,321B 8.28B 7.19B 6.68B 6.16B 11.61B 791B 11.82B 79.09B 30.97B 393B 31.1B 30.42B
Net income 168B 1.06B 917M 851M 785M 1.48B 101B 1.51B 10.08B 3.95B 50.05B 3.96B 3.88B 188B 1.18B 1.02B 949M 876M 1.65B 112B 1.68B 11.24B 4.4B 55.81B 4.42B 4.32B
Net Debt 75.98B 477M 414M 384M 354M 668M 45.49B 680M 4.55B 1.78B 22.59B 1.79B 1.75B 16.78B 105M 91.42M 84.89M 78.29M 147M 10.05B 150M 1.01B 394M 4.99B 395M 387M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
30/07/26 ¥2,415.50 +1.39% 4,730,200
29/07/26 ¥2,382.50 +4.08% 6,546,900
28/07/26 ¥2,289.00 +1.78% 5,281,100
27/07/26 ¥2,249.00 +3.90% 4,788,800
24/07/26 ¥2,164.50 +0.30% 2,693,400
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,415.50JPY
Average target price
3,023.08JPY
Spread / Average Target
+25.15%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock